# BlueHealth Innovation Center

> BlueHealth Innovation Center is a VC fund in Genk backing Health Care and Artificial Intelligence. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Genk, Belgium
- Total investments: 3
- Last investment: Jul 2021
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.bhic.care/

BlueHealth Innovation Center is a VC fund in Genk focused on Health Care and Artificial Intelligence. BlueHealth Innovation Center is driving the digital transformation of healthcare. for Students.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Artificial Intelligence | 2 | 67% |
| Analytics | 1 | 33% |
| Life Science | 1 | 33% |
| Biotechnology | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Asylia Diagnostics | Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transformthese highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing this, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners. | $1.1M | Seed | Jul 12, 2021 |  |
| Kwarts | Kwarts is the AI-driven customer data platform that helps companies to centralize and analyze data streams. | $1.4M | Venture - Series Unknown | Jun 22, 2021 |  |
| Neuroventis | Neuroventis operates as a digital platform for neurology. The Neuroventis platform is a CE-marked medical device that aims to help patients manage and register their neurological disorders and share their health data with their medical team. | $1.2M | Seed | Mar 16, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [imec.istart](https://shizune.co/investors/profile/imec-istart) — VC Fund, 2 deals together
- [Belfius Bank](https://shizune.co/investors/profile/belfius-bank) — VC Fund, 1 deal together
- [Carevolution](https://shizune.co/investors/profile/carevolution) — VC Fund, 1 deal together
- [CAREvolution](https://shizune.co/investors/profile/carevolution-36ac) — VC Fund, 1 deal together
- [Davidovs Venture Collective](https://shizune.co/investors/profile/davidovs-vc) — VC Fund, 1 deal together
- [imec](https://shizune.co/investors/profile/imec) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BlueHealth Innovation Center invest in?

BlueHealth Innovation Center invests primarily in Health Care, Artificial Intelligence and Analytics startups, most often at Seed and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BlueHealth Innovation Center last invest?

The most recent investment recorded for BlueHealth Innovation Center closed in Jul 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co